EDMONTON, Alberta, July 16, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) is pleased to announce that further to its press release of May 20, 2015 it has closed on the entire private placement of 2,500,000 common shares (“Common Shares”) at a price of $0.40 per Common Share for gross proceeds of $1,000,000 (the “Private Placement”). The Corporation intends to use the proceeds from the Private Placement for general working capital.
Pursuant to applicable securities laws, the securities issued under the Private Placement are subject to a minimum four-month hold period from the time of closing of the Private Placement.
No bonus, finder’s fee, commission or agents options have been paid in connection with the closing of the Private Placement.
Additional details regarding the Private Placement can be found in the final Form 9 filed on May 28, 2015 in accordance with the rules of the Canadian Securities Exchange, a copy of which is accessible at www.cnsx.ca under the Corporation’s profile.